THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 121 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $686 | -5.2% | 80,955 | +0.2% | 0.01% | -16.7% |
| Q1 2024 | $724 | -28.5% | 80,755 | -31.2% | 0.01% | -40.0% |
| Q3 2023 | $1,012 | -5.7% | 117,318 | +13.2% | 0.01% | +11.1% |
| Q2 2023 | $1,073 | -99.8% | 103,681 | +92.5% | 0.01% | +28.6% |
| Q1 2022 | $515,000 | +372.5% | 53,850 | +264.1% | 0.01% | +600.0% |
| Q3 2021 | $109,000 | -91.7% | 14,791 | -83.7% | 0.00% | -93.3% |
| Q2 2021 | $1,319,000 | +383.2% | 90,864 | +391.9% | 0.02% | +200.0% |
| Q3 2020 | $273,000 | -58.6% | 18,472 | -41.2% | 0.01% | -70.6% |
| Q2 2020 | $659,000 | – | 31,405 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,157,718 | $17,117,000 | 2.77% |
| Baupost Group | 8,735,168 | $129,149,000 | 1.40% |
| Orbimed Advisors | 6,219,110 | $91,950,000 | 1.16% |
| Rubric Capital Management LP | 550,747 | $8,143,000 | 0.76% |
| Cormorant Asset Management, LP | 650,072 | $9,611,000 | 0.37% |
| Rock Springs Capital Management LP | 824,018 | $12,183,000 | 0.31% |
| Virtus ETF Advisers LLC | 23,148 | $342,000 | 0.18% |
| Tekla Capital Management LLC | 298,470 | $4,413,000 | 0.16% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 412,594 | $6,100,000 | 0.16% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $564,000 | 0.10% |